Healthcare Equipment and Supplies
Company Overview of Glytec, LLC
Glytec, LLC develops glycemic management solutions for diabetes patients worldwide. It offers glycemic management systems for dosage recommendations of insulin, glucose, and saline in appropriate environments. The company offers its products to stabilize excursions and maintain glucose levels within a target range utilizing guardrails that allow patients to achieve normoglycemia while minimizing the risk of cerebral edema, hypoglycemia, cardiac arrest, diabetes ketoacidosis, and neurological trauma. Its systems can be installed locally or operated remotely, including across the Internet. The company was incorporated in 2008 and is based in Greenville, South Carolina. Glytec, LLC operates as ...
665 North Academy Street
Greenville, SC 29601
Founded in 2008
Key Executives for Glytec, LLC
Chief Executive Officer and President
Senior Vice President of Research and Development
Vice President of Clinical Affairs
Medical Advisor and Director
Compensation as of Fiscal Year 2016.
Glytec, LLC Key Developments
CHI Franciscan Health Selects Glytec’s eGMS for Precision Diabetes Management
Sep 22 16
CHI Franciscan Health of Tacoma, Washington has recently turned to Glytec for its comprehensive eGlycemic Management System®, or eGMS®, which includes FDA-cleared technology for both intravenous and subcutaneous real-time insulin dosing. CHI Franciscan will implement Glytec’s eGMS® across all eight of its full-service hospitals. The eGMS® will support glycemic management in critical care and intensive care units as well as medical/surgical floors and emergency departments. The health system has subscribed to multiple eGMS® modules, including Glucommander™, GlucoMetrics®, GlucoSurveillance®, GlucoView® and SmartClick®. The software-as-a-service (SaaS) solution suite offers access to proprietary insulin dosing algorithms, robust analytics and reporting, automated surveillance and alerting, and more. It also offers integration with electronic medical record (EMR) systems and connected devices. The Glytec clinical services organization will work closely with the CHI Franciscan glycemic management committee to tailor the eGMS® to specific workflows, protocols and preferences.
Palmetto Health Selects Glytec's eGlycemic Management System to Support Quality of Care for Patients with Diabetes
Sep 13 16
Palmetto Health has selected Glytec's eGlycemic Management System or eGMS, to support quality of care for patients with diabetes. Palmetto Health will use Glytec's FDA-cleared technology solution as a new standard of care for the 40% of hospitalized patients who require insulin, which includes those with and without diabetes. The cloud-hosted eGMS software-as-a-service solution will be used enterprise-wide, across all of Palmetto Health's clinical disciplines. Palmetto Health selected the Glytec system because they feel it is well aligned with their patient care and quality initiatives. Users will access the eGMS directly from Palmetto Health's Cerner Millenium system via SmartClick, which allows for seamless EMR integration, including single sign-on. Additionally, the analytics and reporting capabilities of the eGMS module, GlucoMetrics will offer clinicians, administrators and executives a means to measure and monitor key performance indicators and other metrics.
13 Additional Health Systems Across the U.S. Selects Glytec's Eglycemic Management System
Jun 4 15
Glytec announced 13 additional health systems across the U.S. have recently selected the company’s eGlycemic Management System (eGMS). Collectively, they represent 37 new hospital implementations. eGMS enables providers, payers, and patients to control glucose levels, and combat the well-documented, spiraling complications and costs associated with diabetes and hyperglycemia. Glytec’s unique eGMS allows providers to embed evidence-based, medical intelligence in the patient care process for those in need of insulin therapy. eGMS provides clinician-developed, algorithm-based software (Glucommander) designed to consider insulin sensitivity and individualize dosing recommendations to address and prevent excursions through all aspects of insulin therapy – including intravenous (IV), transition from IV to subcutaneous (SubQ), SubQ, and pediatric dosing recommendations. The on-going performance and impact of the glycemic control initiative is measured and monitored through Glytec’s GlucoMetrics, a wide array of preset and/or on-demand clinical and business intelligence reports. Additionally, GlucoSurveillance provides real-time capabilities to proactively identify patients who will benefit from glycemic intervention and insulin therapy. eGMS is proven to achieve significantly better control than traditional, manual methods, while simultaneously rendering dangerous hypoglycemic events rare. eGMS facilitates a comprehensive, systems approach to diabetes management, beginning with seamless integration with the EHR. Through the standardization of processes and personalization of treatment, eGMS is proven to reduce infection rates, length-of-stay, readmissions and resource utilization (clinician time as well as supplies).
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|